The government’s Subject Expert Committee has recommended granting approval to Bharat Biotech’s COVID-19 vaccine Covaxin for emergency use among children aged between two and 18 years.
चूहों से छुटकारा पाने के लिए आजमाएं ये Tips…
The Drugs Controller General of India (DCGI) will take the final call. The Hyderabad-based vaccine maker submitted data from Phase 2 and 3 clinical trials on children to DCGI last week.
-NAV GILL
